Trial Profile
A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2011
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Sorafenib (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 18 Aug 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 18 Aug 2011 Planned end date changed from Dec 2010 to Mar 2011 as reported by ClinicalTrials.gov.
- 20 Jul 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.